secwatch.observer — SEC 8-K summary
======================================

Issuer:     Transcode Therapeutics, Inc. (RNAZ)
CIK:        0001829635
Form:       8-K
Filed at:   2025-06-13T23:59:59+00:00
Accession:  0001104659-25-059362
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.08
LLM model:  deepseek-v4-flash:cloud@v2

TransCode sets 2025 annual meeting Aug 29; proposal deadline June 23
--------------------------------------------------------------------

- 2025 Annual Meeting scheduled for August 29, 2025; record date July 11, 2025.
- Stockholder proposals under Rule 14a-8 must be submitted by close of business on June 23, 2025.
- Director nominations and other business also due by June 23, 2025 under universal proxy rules.
- Meeting date is more than 30 days from June 13, 2024 annual meeting, triggering adjusted deadlines.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1829635/000110465925059362/0001104659-25-059362-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1829635/000110465925059362/tm2517990d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-059362

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer